Deal Snapshot
Advanz Pharma Subsidiary Closes USD 76m Acquisition of Correvio Pharma
Thursday 28 May 2020

Mercury Pharma Group Ltd., a subsidiary of Channel Islands-based Advanz Pharma Corp. Ltd. (TSX: ADVZ) has closed the acquisition of all issued and outstanding shares of speciality pharmaceutical company Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), for approximately USD 76m, the company said.

This deal was announced in March. Advanz Pharma said the roughly USD 76m price included debt, and was paid with cash on hand.

Date Published: 28/05/2020